Associate Director, Commercial Analytics, Europe
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the ED, Commercial Excellence, Analytics & Insights (CE&I) Europe, the AD, Commercial Analytics will be leading delivery of core commercial analytics initiatives across Europe, including data governance, reporting, KPI frameworks, launch-readiness analytics, and field effectiveness insights in the lead-up to and through Revolution Medicines’ first European launch.
The incumbent will be a key member of the CE&I team and will be required to partner with a broad ran
